Web Exclusives

submission submit high energy drink substance abuse

Our Readers Respond

The truth about high-energy drinks Re “High-energy drinks: What you don’t know could hurt you” (August article available here): I am very impressed with…

FDA approves new melanoma drug

The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF…

FDA publishes REMS list

Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..

AHRQ releases Spanish medication tracking tool

The Agency for Healthcare Research and Quality has released a newly revised Spanish language medication tracking tool, “Su medicamento: Infórmese. Evite riesgos.” (“Your Medicine:…
submission submit high energy drink substance abuse

Our Readers Respond

The truth about high-energy drinks Re “High-energy drinks: What you don’t know could hurt you” (August article available here): I am very…

FDA approves new melanoma drug

The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have…

FDA publishes REMS list

Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..

Test Your Knowledge

Cannabis TYK

Which of the following best explains why clinicians face challenges in discussing medicinal marijuana with their patients?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.